v3.24.3
Stock Based Compensation
9 Months Ended
Sep. 30, 2024
Share-Based Payment Arrangement [Abstract]  
Stock Based Compensation

(10) Stock Based Compensation

In 2014, the Company adopted a stock compensation plan (the "2014 Equity Incentive Plan") pursuant to which the Company may grant stock options, stock purchase rights, restricted stock awards, or stock awards to employees, directors and consultants (including prospective employees, directors, and consultants). This plan was terminated in February 2016. No additional awards may be granted under the 2014 Equity Incentive Plan, however, outstanding awards continue in full effect in accordance with their existing terms.

In 2016, the Company adopted a stock compensation plan (the “2016 Equity Incentive Plan”) pursuant to which the Company may grant stock options, stock purchase rights, restricted stock awards, or stock awards to employees, directors and consultants (including prospective employees, directors, and consultants). No additional awards may be granted under the 2016 Equity Incentive Plan, however, outstanding awards continue in full effect in accordance with their existing terms.

In connection with the Company’s initial public offering on July 2, 2021, the Company's board of directors adopted the 2021 Equity Incentive Plan (the “2021 Equity Incentive Plan”). The 2021 Equity Incentive Plan provides for the grant of incentive stock options (“ISOs”), non-statutory stock options (“NSOs”), stock appreciation rights, restricted stock awards, restricted stock unit awards, performance-based awards and other awards, or collectively, awards. Awards may be granted to Xometry employees, Xometry’s non-employee directors and consultants/contractors and the employees and consultants/contractors of Xometry affiliates. ISOs may be granted only to Xometry employees and the employees of Xometry affiliates.

As of September 30, 2024, there were 6,761,037 shares available for the Company to grant under the 2021 Equity Incentive Plan.

Stock Options

A summary of the status of the Company’s stock option activity and the changes during the nine months ended September 30, 2024, are as follows (in millions, except share and per share amounts):

 

 

 

Number of
Shares

 

 

Weighted
Average
Exercise Price
Per Share

 

 

Average
Remaining
Contractual
Term

 

 

Aggregate
Intrinsic
Value

 

    Exercisable at December 31, 2023

 

 

1,859,740

 

 

 

8.78

 

 

 

6.4

 

 

 

50.7

 

Balance at December 31, 2023

 

 

2,881,208

 

 

 

12.02

 

 

 

7.0

 

 

 

69.6

 

Granted

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

Exercised

 

 

(527,533

)

 

 

6.77

 

 

 

—

 

 

 

—

 

Forfeited

 

 

(201,418

)

 

 

23.02

 

 

 

—

 

 

 

—

 

Expired

 

 

(48,225

)

 

 

28.11

 

 

 

—

 

 

 

—

 

Balance at September 30, 2024

 

 

2,104,032

 

 

 

11.92

 

 

 

6.1

 

 

 

17.9

 

    Exercisable at September 30, 2024

 

 

1,749,212

 

 

 

10.48

 

 

 

5.8

 

 

 

16.9

 

 

No options were granted during the nine months ended September 30, 2024. The total intrinsic value of options exercised during the nine months ended September 30, 2024 and 2023, was $6.3 million and $2.5 million, respectively.

At September 30, 2024, there was approximately $5.9 million of total unrecognized compensation cost related to unvested stock options. That cost is expected to be recognized over a weighted average period of approximately two years as of September 30, 2024.

The Company currently uses authorized and unissued shares to satisfy share award exercises.

Restricted Stock Units

A summary of the status of the Company’s restricted stock unit activity and the changes during the nine months ended September 30, 2024 are as follows (in millions, except share and per share amounts):

 

 

 

Number of
Shares

 

 

Weighted
Average
Grant Date fair value (per share)

 

 

Aggregate
Intrinsic
Value

 

Unvested RSUs as of December 31, 2023

 

 

1,769,874

 

 

 

22.50

 

 

 

63.6

 

Granted

 

 

1,910,579

 

 

 

18.20

 

 

 

—

 

Vested

 

 

(631,023

)

 

 

21.69

 

 

 

—

 

Forfeited and cancelled

 

 

(554,658

)

 

 

22.15

 

 

 

—

 

Unvested RSUs as of September 30, 2024

 

 

2,494,772

 

 

 

19.49

 

 

 

45.8

 

 

At September 30, 2024, there was approximately $40.3 million of total unrecognized compensation cost related to unvested restricted stock units granted under the 2021 Equity Incentive Plan. That cost is expected to be recognized over a weighted average period of approximately three years as of September 30, 2024.

 

Performance Restricted Stock Units

A summary of the status of the Company's performance restricted stock unit activity and the changes during the nine months ended September 30, 2024 are as follows (in millions, except share and per share amounts):

 

 

Number of
Shares

 

 

Weighted
Average
Grant Date fair value (per share)

 

 

Aggregate
Intrinsic
Value

 

Unvested PRSUs as of December 31, 2023

 

 

—

 

 

 

—

 

 

 

—

 

Granted

 

 

336,118

 

 

 

17.35

 

 

 

—

 

Vested

 

 

-

 

 

 

-

 

 

 

—

 

Forfeited and cancelled

 

 

(63,603

)

 

 

17.48

 

 

 

—

 

Unvested PRSUs as of September 30, 2024

 

 

272,515

 

 

 

17.32

 

 

 

5.0

 

 

At September 30, 2024, there was approximately $3.9 million of total unrecognized compensation cost related to unvested performance restricted stock units granted under the 2021 Equity Incentive Plan. That cost is expected to be recognized over a weighted average period of approximately two years as of September 30, 2024.

Total stock-based compensation cost for the three and nine months ended September 30, 2024 and 2023 were as follows (in thousands):

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

 

 

 

 

 

 

 

 

 

 

Sales and marketing

 

$

1,905

 

 

$

1,216

 

 

$

5,825

 

 

$

3,453

 

Operations and support

 

 

2,235

 

 

 

1,955

 

 

 

6,568

 

 

 

5,690

 

Product development

 

 

1,520

 

 

 

1,424

 

 

 

4,770

 

 

 

3,890

 

General and administrative

 

 

1,294

 

 

 

1,135

 

 

 

3,952

 

 

 

3,189

 

Total stock compensation expense

 

$

6,954

 

 

$

5,730

 

 

$

21,115

 

 

$

16,222